Traws Pharma, Inc. (TRAW) Net margin 2016–2024
Traws Pharma, Inc. (TRAW) net profit margin by fiscal year — reported net income divided by reported revenue.
-5968.6%FY2024 · since FY2016: -2499.0% → -5968.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -5968.6% | +2415.5 pp |
| FY2023 | -8384.1% | +7.1 pp |
| FY2022 | -8391.2% | -1239.4 pp |
| FY2021 | -7151.8% | +3979.6 pp |
| FY2020 | -11131.4% | -1822.8 pp |
| FY2019 | -9308.7% | -8366.2 pp |
| FY2018 | -942.4% | +1019.5 pp |
| FY2017 | -1961.9% | +537.1 pp |
| FY2016 | -2499.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice